$117 Million
Joint Bookrunner
Follow-On
January 2014
Up to $60 Million
Exclusive Financial Advisor
Sale to AtriCure, Inc.
December 2013
Not Disclosed
Exclusive Financial Advisor
Global License & Option Agreement with Takeda Pharmaceutical Co. Ltd.
December 2013
$155M + $1.8B Milestones
Exclusive Financial Advisor
Collaboration with Celgene
December 2013
$197 Million
Joint Bookrunner
Follow-On
December 2013
$115 Million
Joint Bookrunner
Convertible Debt
December 2013
$81 Million
Joint Bookrunner
Initial Public Offering
December 2013
$90 Million
Co-Manager
Follow-On
November 2013
$62 Million
Joint Bookrunner
Follow-On
November 2013
$125 Million
Joint Bookrunner
Initial Public Offering
November 2013
$69 Million
Joint Bookrunner
Follow-On
November 2013
$90 Million
Co-Manager
Follow-On
November 2013